Cargando…
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082857/ https://www.ncbi.nlm.nih.gov/pubmed/30089794 http://dx.doi.org/10.1038/s12276-018-0115-0 |